Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sandra Acholonu"'
Autor:
Paolo Anderlini, Rima Saliba, Sandra Acholonu, Sergio A. Giralt, Borje Andersson, Naoto T. Ueno, Chitra Hosing, Issa F. Khouri, Daniel Couriel, Marcos de Lima, Muzaffar H. Qazilbash, Barbara Pro, Jorge Romaguera, Luis Fayad, Frederick Hagemeister, Anas Younes, Mark F. Munsell, Richard E. Champlin
Publikováno v:
Haematologica, Vol 93, Iss 2 (2008)
Background The role of reduced-intensity conditioning allogeneic stem cell transplantation in relapsed/refractory Hodgkin’s lymphoma remains poorly defined. We here present an update of our single-center experience with fludarabine-melphalan as a p
Externí odkaz:
https://doaj.org/article/f696d37c79e84d12b3773142c55de1ee
Autor:
Chitra Hosing, Christina Chancoco, Stefan O. Ciurea, Amin M. Alousi, Issa F. Khouri, Celina Ledesma, Anas Younes, Richard E. Champlin, Rima M. Saliba, Yago Nieto, Uday R. Popat, Michelle A. Fanale, Rosamar Valverde, Sandra Acholonu, Paolo Anderlini, Elizabeth J. Shpall
Publikováno v:
Leukemia & Lymphoma. 53:499-502
Progressive disease (PD) remains the main cause of treatment failure following reduced-intensity conditioning (RIC) allogeneic stem cell transplant (allo-SCT) in Hodgkin lymphoma (HL) [1]. The dise...
Autor:
Roy B. Jones, Rima M. Saliba, Anas Younes, Martin Korbling, Luis Fayad, Barbara Pro, Issa F. Khouri, Michele L. Donato, Paolo Anderlini, Marcos de Lima, Daniel R. Couriel, Grace Julia Okoroji, Sandra Acholonu, Peter McLaughlin, Elizabeth J. Shpall, John T. Manning, Richard E. Champlin, Farzaneh Maadani, Segio Giralt, Chitra Hosing
Publikováno v:
Journal of Clinical Oncology. 23:2240-2247
Purpose We investigated the efficacy and safety of administering high-dose rituximab (HD-R) in combination with high-dose carmustine, cytarabine, etoposide, and melphalan chemotherapy and autologous stem-cell transplantation (SCT) in patients with re
Autor:
Richard E. Champlin, Naoto T. Ueno, Issa F. Khouri, Sergio Giralt, M. Donato, G-J Okoroji, M. de Lima, Borje S. Andersson, Paolo Anderlini, Daniel R. Couriel, Sandra Acholonu
Publikováno v:
Bone Marrow Transplantation. 34:511-514
Nine patients with advanced Hodgkin's lymphoma (HL) who had undergone allogeneic stem cell transplantation (allo-SCT) received donor leukocyte infusions (DLIs) for treatment of persistent or progressive disease (PD). A total of 15 DLIs were performed
Autor:
Issa F. Khouri, Naoto T. Ueno, Sandra Acholonu, Peter McLaughlin, Luis Fayad, Richard E. Champlin, Michele L. Donato, Rima M. Saliba, Maricer P. Escalon, Farzaneh Maadani, Barbara Pro, Chitra Hosing, Sergio Giralt
Publikováno v:
Journal of Clinical Oncology. 22:2419-2423
Purpose Allogeneic transplantation for patients with lymphoma who experience a recurrence after an autologous transplantation has been considered a hazardous therapeutic choice. We investigated the safety and efficacy of nonmyeloablative stem-cell tr
Autor:
Richard E. Champlin, Sandra Acholonu, Peter McLaughlin, Ruth L. Katz, Luis Fayad, Anas Younes, Rima M. Saliba, Issa F. Khouri, Barbara Pro, Gu Jun, Ming S. Lee
Publikováno v:
Journal of Clinical Oncology. 21:4407-4412
Purpose: Patients with relapsed mantle-cell lymphoma have poor prognosis and short survival. Our aim was to determine the efficacy of nonablative allogeneic stem-cell transplantation in patients with relapsed mantle-cell lymphoma. Patients and Method
Autor:
Rima M. Saliba, Sandra Acholonu, Uday R. Popat, Naoto T. Ueno, Paolo Anderlini, Roy B. Jones, Richard E. Champlin, Muzaffar H. Qazilbash, Marcos de Lima, Sergio Giralt, Grace Julia Okoroji, Yago Nieto, Chitra Hosing, Borje S. Andersson, Celina Ledesma
Publikováno v:
Leukemia & Lymphoma. 53:1239-1241
Progressive disease remains the main cause of treatment failure following allogeneic stem cell transplantation (allo-SCT) for Hodgkin lymphoma (HL), and the role of donor leukocyte infusions (DLIs) in the management of disease recurrence is still bei
Autor:
Elizabeth J. Shpall, Muzaffar H. Qazilbash, Laura L. Worth, Uday R. Popat, Roland Bassett, Richard E. Champlin, Paolo Anderlini, Sergio Giralt, Grace Julia Okoroji, Sandra Acholonu
Publikováno v:
Leukemialymphoma. 52(1)
Twenty severe aplastic anemia (SAA) patients underwent allogeneic stem cell transplantation (allo-SCT) with fludarabine (FLU), cyclophosphamide and antithymocyte globulin from a matched related (n=7, age ≥ 40) or unrelated donor (n=13, any age). Me
Autor:
Rima M. Saliba, Jorge E. Romaguera, Muzaffar H. Qazilbash, Richard E. Champlin, Anas Younes, Frederick B. Hagemeister, Marcos de Lima, Sergio Giralt, Naoto T. Ueno, Issa F. Khouri, Luis Fayad, Barbara Pro, Paolo Anderlini, Borje S. Andersson, Chitra Hosing, Mark F. Munsell, Daniel R. Couriel, Sandra Acholonu
Publikováno v:
Haematologica. 93(2)
Background The role of reduced-intensity conditioning allogeneic stem cell transplantation in relapsed/refractory Hodgkin’s lymphoma remains poorly defined. We here present an update of our single-center experience with fludarabine-melphalan as a p
Autor:
Martin Korbling, Marcos de Lima, Sergio Giralt, Grace Julia Okoroji, Daniel R. Couriel, Michele L. Donato, Rima M. Saliba, Sandra Acholonu, Richard E. Champlin, Issa F. Khouri, John McMannis, Paolo Anderlini, Chitra Hosing
Publikováno v:
Leukemialymphoma. 47(7)
Rituximab, an anti-CD20 human-mouse chimeric monoclonal antibody has been shown to improve response rates when it is combined with standard salvage chemotherapy in patients with relapsed or refractory intermediate-grade B-cell non-Hodgkin's lymphoma.